Дело C-599/24: Accord Healthcare/Ferring Pharmaceuticals и Комисия, Определение от 4 октомври 2024 г.

Текст

... rd – Action for annulment – Time limits – Force majeure or unforeseeable circumstances – Dismissal )

In Case C‑599/24 P(I),

APPEAL under the first paragraph of Article 57 of the Statute of the Court of Justice of the European Union, brought on 16 September 2024,

Accord Healthcare SL, established in Barcelona (Spain), represented by C. Drew and G. Morgan, Solicitors, and by T. Johnston, Barrister,

appellant,

the other parties to the proceedings being:

Ferring Pharmaceuticals A/S, established in Kastrup (Denmark),

applicant at first instance,

European Commission,

defendant at first instance,

THE VICE-PRESIDENT OF THE COURT,

after hearing the Advocate General, M. Szpunar,

makes the following

Order

1. By its appeal, Accord Healthcare SL asks the Court of Justice to set aside the order of the President of the Eighth Chamber of the General Court of the European Union of 26 August 2024, Ferring Pharmaceuticals v Commission (T‑12/24, EU:T:2024:573; ‘the order under appeal’), by which the President of the Eighth Chamber dismissed Accord Healthcare SL’s application for leave to intervene in support of the form of order sought by the European Commission in Case T‑12/24.

The procedure before the General Court and the order under appeal

2. By application lodged at the Registry of the General Court on 10 January 2024, Ferring Pharmaceuticals A/S brought an action for annulment of Commission Implementing Decision C(2023) 6669 final of 29 September 2023 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for ‘Degarelix Accord – ...